Catalyst Wire Dossier Catalyst Wire Dossier

CY 4031 (VITALITY-ALS program)

· Cytokinetics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CY 4031 (VITALITY-ALS program), covering 2021-05-12 to 2021-05-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study for Patients Who Completed VITALITY-ALS (CY 4031) [Phase 3]

See pricing